These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37378945)

  • 21. [The expression of ki-67, topoIIalpha in laryngeal squamous cell carcinoma].
    Deng G; Yang C; Chen W
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 May; 19(9):396-8. PubMed ID: 16075972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study.
    Brustmann H
    Gynecol Oncol; 2004 Jan; 92(1):268-76. PubMed ID: 14751170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topoisomerase IIa Protein Expression Patterns in Laryngeal Squamous Cell Carcinoma.
    Papanikolaou V; Chrysovergis A; Mastronikolis N; Tsiambas E; Ragos V; Peschos D; Stavraka C; Roukas D; Kyrodimos E
    Anticancer Res; 2020 Feb; 40(2):807-811. PubMed ID: 32014923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue microarray analysis of topoisomerase IIalpha protein in gastric adenocarcinomas: histogenetic and prognostic implications.
    Wang G; Huang H; Gao J; Chen P; You W; Wu B; Wang M
    Cancer Genomics Proteomics; 2011; 8(3):127-33. PubMed ID: 21518818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topoisomerase II alpha expression in esophageal squamous cell carcinoma.
    Ohashi Y; Sasano H; Yamaki H; Shizawa S; Kikuchi A; Shineha R; Akaishi T; Satomi S; Nagura H
    Anticancer Res; 1999; 19(3A):1873-80. PubMed ID: 10470130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of topoisomerase I/topoisomerase IIalpha status in esophageal cancer.
    Hanagiri T; Ono K; Kuwata T; Takenaka M; Oka S; Chikaishi Y; Shigematsu Y; Nagata Y; Shimokawa H; Nakagawa M; Uramoto H; So T; Tanaka F
    J UOEH; 2011 Sep; 33(3):205-16. PubMed ID: 21913377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA topoisomerase II alpha: a favorable prognostic factor in colorectal caner.
    Gao XH; Yu ZQ; Zhang C; Bai CG; Zheng JM; Fu CG
    Int J Colorectal Dis; 2012 Apr; 27(4):429-35. PubMed ID: 22076611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
    Lynch BJ; Guinee DG; Holden JA
    Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of topoisomerase II alpha, Ki-67 and p53 in early stage laryngeal carcinomas not featuring vocal cord fixation.
    Horibe Y; Murakami M; Komori K; Imaeda Y; Kasahara M
    APMIS; 2000 Oct; 108(10):689-96. PubMed ID: 11200824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topoisomerase II-alpha expression in melanocytic nevi and malignant melanoma.
    Mu XC; Tran TA; Ross JS; Carlson JA
    J Cutan Pathol; 2000 May; 27(5):242-8. PubMed ID: 10847549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.
    Kreisholt J; Sorensen M; Jensen PB; Nielsen BS; Andersen CB; Sehested M
    Br J Cancer; 1998 May; 77(9):1469-73. PubMed ID: 9652763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
    Kimura F; Kawamura J; Watanabe J; Kamoshida S; Kawai K; Okayasu I; Kuwao S
    Diagn Cytopathol; 2010 Mar; 38(3):161-7. PubMed ID: 19821496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of immunohistochemical determination of topoisomerase IIα and Ki67 as markers of cell proliferation and malignant transformation in colonic mucosa.
    Stromar IK; Jakic-Razumovic J
    Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):524-9. PubMed ID: 24185119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival.
    Zhao H; Yu H; Liu Y; Wang Y; Cai W
    Clin Neuropathol; 2008; 27(2):83-90. PubMed ID: 18402387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topoisomerase IIalpha expression in ductal carcinoma in situ of the breast: a preliminary study.
    Shpitz B; Bomstein Y; Zehavi T; Bernheim J; Liverant S; Kaufman Z; Buklan G; Klein E
    Hum Pathol; 2000 Oct; 31(10):1249-54. PubMed ID: 11070118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen SM; Favalli C; Syrjänen K;
    Int J Gynecol Pathol; 2006 Oct; 25(4):383-92. PubMed ID: 16990717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancer.
    Durbecq V; Desmed C; Paesmans M; Cardoso F; Di Leo A; Mano M; Rouas G; Leroy JY; Sotiriou C; Piccart M; Larsimont D
    Int J Oncol; 2004 Nov; 25(5):1473-9. PubMed ID: 15492841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
    Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J
    J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
    Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.